Full Agenda Revealed: 2026 XtalPi AI-Driven Drug Discovery Innovation Summit

Blog details
5 min read
Share this:

Date: June 12, 2026 | 09:00 – 17:30 (CST)

Venue: Hilton Shanghai Zhangjiang Science City

Organizer: XtalPi

The 2026 summit serves as a premier platform, bringing together leading academics, industry executives, and technical pioneers from across the global life sciences sector. For this summit, XtalPi’s co-founder and executive team will share the stage with academic representatives from the Chinese Academy of Sciences (CAS) and R&D leaders from frontrunner biotechs.

Through a comprehensive agenda of keynotes, panel discussions, and dedicated networking sessions, attendees will gain an objective look at macro industry trends, breakthrough technologies, and new opportunities for ecosystem collaboration.

In collaboration with forward-thinking innovators and global strategic partners, we will showcase a selection of proprietary, highly differentiated pipeline programs. These technical presentations will focus directly on high-barrier therapeutic areas, including oncology, autoimmune diseases, metabolic disorders, and central nervous system (CNS) diseases.

The scientific sessions will feature deep dives into:

  • Brain-penetrant PRMT5 inhibitors
  • Oral GLP-1R agonists
  • Organoid-driven, AI-targeted therapeutics
  • Novel autoimmune disease treatments
  • Small molecule RNA modulators
  • Novel therapies for idiopathic pulmonary fibrosis (IPF)

To provide additional business value, industry experts will also analyze current cross-border Business Development trends and differentiated R&D strategies designed to accelerate pipeline optimization and successful asset translation.

A central focus of the summit will be the live demonstration of XtalPi’s core computational technologies, featuring the latest updates to our ID4Inno™ small molecule drug discovery platform. We will explore how the integration of advanced AI and physics-based models redefines the traditional drug discovery paradigm.

Crucially, this dual-model framework operates in tandem with our industry-leading, automated “wet-dry” closed-loop laboratory workflow. Through validated computational data and real-world case studies, we will demonstrate how AI tangibly improves efficiency, reduces costs, and accelerates timelines, ultimately establishing an intelligent “Technology-Pipeline-Commerce” lifecycle.

We cordially invite academic researchers, industry professionals, and strategic partners from around the world to join this high-level exchange. For our international audience, the entire summit will be broadcast live globally. Please click the link below to reserve your virtual access.

Your next success starts here

Recommended articles

XtalPi – Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
XtalPi’s AI + Robotics Platform Powers First Clinical Milestone for ReviR’s Rare Neurological Drug RTX-117
Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant – Successful Launch of Advanced Automated Workstation at BASF
XtalPi and VISEN Pharmaceuticals Enter Strategic Partnership to Co-Develop Innovative Endocrine Therapies for a Multi-Billion Dollar Market

XtalPi Newsletter